Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Nov;76(11):651–655. doi: 10.1136/bjo.76.11.651

Prognostic importance of ophthalmic manifestations in childhood leukaemia.

K Ohkoshi 1, W G Tsiaras 1
PMCID: PMC504367  PMID: 1477038

Abstract

In order to assess the systemic prognosis of children with leukaemic ocular involvement, 63 of 131 patients admitted to hospital with acute leukaemia were evaluated ophthalmically. A total of 28 of 63 showed ophthalmic involvement and were followed up for up to 84 months. Twenty seven of 28 patients (96.4%) died within 28 months after the onset of ocular involvement and within 83 months after the onset of leukaemia. The 5 year survival rate of patients with ophthalmic manifestations was 21.4% (6/28). This survival rate was significantly lower than that of those who lacked ophthalmic manifestations (16/35: 45.7%, p < 0.05). All of the patients with ophthalmic manifestations had either bone marrow relapse or central nervous system leukaemia. The prognosis was related to risk factors such as central nervous system leukaemia or bone marrow relapse in most cases.

Full text

PDF
655

Images in this article

653Image
on p.653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN R. A., STRAATSMA B. R. Ocular involvement in leukemia and allied disorders. Arch Ophthalmol. 1961 Oct;66:490–508. doi: 10.1001/archopht.1961.00960010492010. [DOI] [PubMed] [Google Scholar]
  2. Bleyer W. A. Central nervous system leukemia. Pediatr Clin North Am. 1988 Aug;35(4):789–814. doi: 10.1016/s0031-3955(16)36510-5. [DOI] [PubMed] [Google Scholar]
  3. CULLER A. M. Fundus changes in leukemia. Trans Am Soc Ophthalmol Otolaryngol Allergy. 1951;49:445–473. [PubMed] [Google Scholar]
  4. Curto M. L., Zingone A., Acquaviva A., Bagnulo S., Calculli L., Cristiani L., Dini G., Di Tullio M. T., Guazzelli C., Jancovic M. Leukemic infiltration of the eye: results of therapy in a retrospective multicentric study. Med Pediatr Oncol. 1989;17(2):134–139. doi: 10.1002/mpo.2950170212. [DOI] [PubMed] [Google Scholar]
  5. Kincaid M. C., Green W. R. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983 Jan-Feb;27(4):211–232. doi: 10.1016/0039-6257(83)90123-6. [DOI] [PubMed] [Google Scholar]
  6. Leonardy N. J., Rupani M., Dent G., Klintworth G. K. Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol. 1990 Apr 15;109(4):436–444. doi: 10.1016/s0002-9394(14)74610-0. [DOI] [PubMed] [Google Scholar]
  7. MAHNEKE A., VIDEBAEK A. ON CHANGES IN THE OPTIC FUNDUS IN LEUKAEMIA. AETIOLOGY, DIAGNOSTIC AND PROGNOSTIC ROLE. Acta Ophthalmol (Copenh) 1964;42:201–210. doi: 10.1111/j.1755-3768.1964.tb07865.x. [DOI] [PubMed] [Google Scholar]
  8. Ohkoshi K. [Ocular manifestations of childhood leukemia]. Nippon Ganka Gakkai Zasshi. 1988 Nov;92(11):1787–1796. [PubMed] [Google Scholar]
  9. Poplack D. G., Reaman G. Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1988 Aug;35(4):903–932. doi: 10.1016/s0031-3955(16)36515-4. [DOI] [PubMed] [Google Scholar]
  10. Ridgway E. W., Jaffe N., Walton D. S. Leukemic ophthalmopathy in children. Cancer. 1976 Oct;38(4):1744–1749. doi: 10.1002/1097-0142(197610)38:4<1744::aid-cncr2820380449>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Schachat A. P., Markowitz J. A., Guyer D. R., Burke P. J., Karp J. E., Graham M. L. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989 May;107(5):697–700. doi: 10.1001/archopht.1989.01070010715033. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES